← Back to Analyst Consensus 
BCO Buy
BRINKS CO
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Mar 2, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Feb 10, 2026 | Truist Securities | maintain | Buy → Buy | $163 | 54% |
| Nov 7, 2024 | Truist Securities | maintain | Buy → Buy | $138 | 54% |
| Sep 20, 2024 | Truist Securities | maintain | Buy → Buy | $144 | 54% |
| May 21, 2024 | William Blair | initiate | — → Outperform | $0 | 48% |
| Mar 1, 2024 | Goldman Sachs | maintain | Buy → Buy | $103 | 54% |
| Feb 28, 2024 | Truist Securities | maintain | Buy → Buy | $110 | 54% |
| Aug 10, 2023 | Goldman Sachs | maintain | Buy → Buy | $92 | 54% |
| Mar 24, 2023 | Truist Securities | maintain | — → Buy | $90 | 54% |
| May 7, 2020 | Imperial Capital | maintain | — → Outperform | $80 | — |
| Apr 20, 2020 | SunTrust Robinson Humphrey | maintain | — → Buy | $80 | — |
| Nov 20, 2019 | Goldman Sachs | initiate | — → Buy | $108 | 54% |
| Sep 4, 2019 | Buckingham Research | maintain | — → Neutral | $105 | — |
| Jul 25, 2019 | Imperial Capital | maintain | — → Outperform | $105 | — |
| Jun 1, 2018 | Buckingham Research | maintain | Buy → Buy | $110 | — |
| Mar 27, 2018 | Buckingham Research | initiate | — → Buy | $100 | — |
| Aug 9, 2017 | Imperial Capital | upgrade | In-Line → Outperform | $0 | — |
| Feb 28, 2017 | SunTrust Robinson Humphrey | initiate | — → Buy | $62 | — |
| Oct 28, 2016 | Imperial Capital | downgrade | Outperform → In-Line | $0 | — |
| Sep 16, 2016 | Macquarie | maintain | — → Neutral | $38 | 56% |
| Aug 3, 2016 | Imperial Capital | upgrade | In-Line → Outperform | $38 | — |
| May 6, 2015 | Imperial Capital | downgrade | Outperform → In-Line | $30 | — |
| May 6, 2015 | Gabelli & Co. | upgrade | Hold → Buy | $0 | — |
| Apr 23, 2015 | Macquarie | downgrade | Outperform → Neutral | $31 | 56% |
| Mar 24, 2015 | Standpoint Research | downgrade | Buy → Hold | $0 | — |
| Mar 19, 2015 | Macquarie | initiate | — → Outperform | $34 | 56% |
| Dec 5, 2014 | Standpoint Research | initiate | — → Buy | $32 | — |
| Nov 5, 2014 | Imperial Capital | downgrade | Outperform → In-Line | $27 | — |
| Apr 16, 2014 | Imperial Capital | downgrade | Outperform → In-Line | $27 | — |
| Jan 6, 2014 | Imperial Capital | maintain | — → Outperform | $38 | — |
| Oct 29, 2013 | Imperial Capital | maintain | — → Outperform | $35 | — |
| May 2, 2013 | Imperial Capital | initiate | — → Outperform | $31 | — |
| Feb 5, 2013 | Imperial Capital | maintain | — → Outperform | $31 | — |
| Jan 22, 2013 | Imperial Capital | maintain | — → Outperform | $33.5 | — |
| Oct 31, 2012 | Imperial Capital | maintain | — → Outperform | $31 | — |
| May 1, 2012 | Imperial Capital | maintain | — → Outperform | $33 | — |
Price Target Trend
May 28, 2026 Latest: $146.33 Oct 24, 2026
EPS Estimates
0y $9.20
Lo: $9.13 Hi: $9.23
3 analysts ▲1
+1y $10.35
Lo: $10.15 Hi: $10.60
3 analysts +1q $2.83
Lo: $2.77 Hi: $2.87
3 analysts 0q $2.43
Lo: $2.42 Hi: $2.43
3 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days